Stockscreener 앱 받기
112.29
0.94%
-1.00
전일 마감가:
$113.29
열려 있는:
$113.01
하루 거래량:
2.15M
Relative Volume:
0.25
시가총액:
$195.22B
수익:
$44.33B
순이익/손실:
$6.48B
주가수익비율:
30.32
EPS:
3.7033
순현금흐름:
$6.92B
1주 성능:
+0.67%
1개월 성능:
-7.84%
6개월 성능:
-14.50%
1년 성능:
-15.07%
1일 변동 폭
$112.15
$113.40
1주일 범위
$111.40
$113.59
52주 변동 폭
$105.27
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT vs SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
112.27 | 197.00B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
370.80 | 144.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
97.80 | 126.27B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.00 | 113.12B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
77.95 | 45.83B | 6.07B | 1.06B | 799.60M | 1.8527 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Hemenway Trust Co LLC Has $45.81 Million Holdings in Abbott Laboratories $ABT - MarketBeat
ABT.SW Abbott Laboratories CHF100.00 pre-market 19 Feb 2026: Oversold bounce - Meyka
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott (NYSE:ABT) Diagnostics Strength Supports Russell 1000 ETF Narrative - Kalkine Media
How The Abbott Offer Is Rewriting The Story For Exact Sciences (EXAS) - Yahoo Finance
NEOS Investment Management LLC Acquires 72,502 Shares of Abbott Laboratories $ABT - MarketBeat
Merit Financial Group LLC Grows Holdings in Abbott Laboratories $ABT - MarketBeat
Skandinaviska Enskilda Banken AB publ Buys 190,255 Shares of Abbott Laboratories $ABT - MarketBeat
A Look At Abbott Laboratories (ABT) Valuation As Libre 3 Lawsuit Raises Product Safety Concerns - simplywall.st
Abbott class action claims glucose sensors sold with defect - Class Action Lawsuits
Southeast Asset Advisors LLC Acquires 9,600 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Vanguard Group Inc. - MarketBeat
Pallas Capital Advisors LLC Reduces Stock Position in Abbott Laboratories $ABT - MarketBeat
Shell Asset Management Co. Trims Stock Position in Abbott Laboratories $ABT - MarketBeat
Fifth Third Bancorp Sells 10,616 Shares of Abbott Laboratories $ABT - MarketBeat
State of New Jersey Common Pension Fund D Boosts Holdings in Abbott Laboratories $ABT - MarketBeat
PNC Financial Services Group Inc. Reduces Position in Abbott Laboratories $ABT - MarketBeat
Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects? - Yahoo Finance
GF Fund Management CO. LTD. Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
HighTower Advisors LLC Sells 35,569 Shares of Abbott Laboratories $ABT - MarketBeat
Aberdeen Group plc Sells 49,223 Shares of Abbott Laboratories $ABT - MarketBeat
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Abbott Laboratories (ABT) - The Globe and Mail
What is Abbott Laboratories s 5 year growth outlookWeekly Gains Summary & Smart Swing Trading Alerts - mfd.ru
Key facts: Exact Sciences to merge with Abbott by Q2 2026; 2025 revenue up 18% - TradingView
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio - GuruFocus
EXACT SCIENCES CORP SEC 10-K Report - TradingView
ABT.SW Abbott Laboratories (SIX) volume spike 40x avg: watch CHF100.00 support - Meyka
Abbott Laboratories $ABT Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Krilogy Financial LLC Acquires Shares of 9,560 Abbott Laboratories $ABT - MarketBeat
Freemont Management S.A. Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories: A Steady Dividend Growth King - Intellectia AI
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next? - 24/7 Wall St.
DexCom earnings up next: Can G7 rollout offset Abbott competition? By Investing.com - Investing.com Nigeria
DexCom earnings up next: Can G7 rollout offset Abbott competition? - Investing.com
Abbott Laboratories $ABT Shares Bought by Varma Mutual Pension Insurance Co - MarketBeat
Abbott Labs: The healthcare dividend stock I'd happily hold forever - MSN
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever - AOL.com
Illinois Municipal Retirement Fund Has $22.46 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Cibc World Market Inc. Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Caisse Des Depots ET Consignations Buys 9,374 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Atria Investments Inc - MarketBeat
‘Time to Buy,’ Says Options Trader Following Abbott’s (ABT) Earnings Implosion - TipRanks
Rhumbline Advisers Sells 57,100 Shares of Abbott Laboratories $ABT - MarketBeat
Seaview Investment Managers LLC Reduces Position in Abbott Laboratories $ABT - MarketBeat
Jensen Investment Management Inc. Has $322.72 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Drug of Abuse Testing Market Is Going to Boom |• Abbott - openPR.com
Impax Asset Management Group plc Sells 13,701 Shares of Abbott Laboratories $ABT - MarketBeat
Caprock Group LLC Takes Position in Abbott Laboratories $ABT - MarketBeat
ING Groep NV Has $63.40 Million Holdings in Abbott Laboratories $ABT - MarketBeat
US Says Abbott Lied, Must Repay Funds Spent On Formula - Law360
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
자본화:
|
볼륨(24시간):